newsfilter
← Latest News
GlobeNewswire·

TRACON to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 10, 2022

SAN DIEGO, July 27, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer ther